Testing previous model predictions against new data on human papillomavirus vaccination program outcomes.

ABSTRACT:

Background

Vaccination against human papillomavirus (HPV), predominantly targeting young females, has been introduced in many countries. Decisions to implement programs, which have involved substantial investment by governments, have in part been based on findings from cost-effectiveness models. Now that vaccination programs have been in place for some years, it is becoming possible to observe their effects, and compare these with model effectiveness predictions made previously.

Findings

Australia introduced a publicly-funded HPV vaccination program in 2007. Recently reported Australian data from a repeat cross-sectional survey showed a substantial (77%) fall in HPV16 prevalence in women aged 18-24 years in 2010-2011, compared to pre-vaccination levels. We have previously pu

SUBMITTER: Smith MA 

PROVIDER: S-EPMC3938033 | biostudies-literature | 2014 Feb

REPOSITORIES: biostudies-literature